Zhejiang Tailin Bioengineering Co Ltd (300813) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.053x

Based on the latest financial reports, Zhejiang Tailin Bioengineering Co Ltd (300813) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥42.25 Million ≈ $6.18 Million USD) by net assets (CN¥804.29 Million ≈ $117.69 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Tailin Bioengineering Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Zhejiang Tailin Bioengineering Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Zhejiang Tailin Bioengineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Tailin Bioengineering Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Tailin Bioengineering Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zhejiang Busen Garments Co Ltd
SHE:002569
-0.564x
Shenzhen Jianyi Decoration Group Co Ltd
SHE:002789
0.236x
Natures Sunshine Products Inc
NASDAQ:NATR
-0.011x
Guizhou Wire Rope Co Ltd
SHG:600992
-0.004x
Power Wind Health Industry Incorporated
TW:8462
0.239x
Australian Ethical Investment Ltd
AU:AEF
0.297x
Genie Energy Ltd
NYSE:GNE
-0.027x
Ausgold Ltd
AU:AUC
-0.012x

Annual Cash Flow Conversion Efficiency for Zhejiang Tailin Bioengineering Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Tailin Bioengineering Co Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Zhejiang Tailin Bioengineering Co Ltd worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥804.29 Million
≈ $117.69 Million
CN¥57.11 Million
≈ $8.36 Million
0.071x +136.34%
2024-12-31 CN¥820.73 Million
≈ $120.10 Million
CN¥24.66 Million
≈ $3.61 Million
0.030x +911.17%
2023-12-31 CN¥650.24 Million
≈ $95.15 Million
CN¥1.93 Million
≈ $282.70K
0.003x -97.85%
2022-12-31 CN¥647.45 Million
≈ $94.74 Million
CN¥89.39 Million
≈ $13.08 Million
0.138x +90.94%
2021-12-31 CN¥497.38 Million
≈ $72.78 Million
CN¥35.96 Million
≈ $5.26 Million
0.072x -69.78%
2020-12-31 CN¥444.24 Million
≈ $65.01 Million
CN¥106.28 Million
≈ $15.55 Million
0.239x +88.75%
2019-12-31 CN¥229.11 Million
≈ $33.53 Million
CN¥29.04 Million
≈ $4.25 Million
0.127x -33.89%
2018-12-31 CN¥194.70 Million
≈ $28.49 Million
CN¥37.33 Million
≈ $5.46 Million
0.192x +21.87%
2017-12-31 CN¥146.48 Million
≈ $21.44 Million
CN¥23.04 Million
≈ $3.37 Million
0.157x -42.03%
2016-12-31 CN¥116.31 Million
≈ $17.02 Million
CN¥31.56 Million
≈ $4.62 Million
0.271x +7.74%
2015-12-31 CN¥97.42 Million
≈ $14.26 Million
CN¥24.54 Million
≈ $3.59 Million
0.252x -20.82%
2014-12-31 CN¥55.04 Million
≈ $8.05 Million
CN¥17.51 Million
≈ $2.56 Million
0.318x +79.38%
2013-12-31 CN¥64.92 Million
≈ $9.50 Million
CN¥11.51 Million
≈ $1.68 Million
0.177x --

About Zhejiang Tailin Bioengineering Co Ltd

SHE:300813 China Medical Devices
Market Cap
$347.26 Million
CN¥2.37 Billion CNY
Market Cap Rank
#14239 Global
#4260 in China
Share Price
CN¥19.58
Change (1 day)
+0.10%
52-Week Range
CN¥18.88 - CN¥40.33
All Time High
CN¥64.43
About

Zhejiang Tailin BioEngineering Co.,Ltd research and development, production, and sells microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. It primarily provides aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technology products. The company … Read more